Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences
- Written by PR Newswire
SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Aug. 29, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the management team...
Read more: Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences